State Of Wyoming Gilead Sciences, Inc. Transaction History

State Of Wyoming

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $89,357 - $103,125	1,415 Added 49.74%	4,260 $292,000
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $161,842 - $197,362	2,261 Added 387.16%	2,845 $208,000
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $202,005 - $229,079	-2,757 Reduced 82.52%	584 $47,000
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $19,446 - $21,216	-263 Reduced 7.3%	3,341 $250,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $85,587 - $97,624	1,126 Added 45.44%	3,604 $277,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $47,932 - $54,609	620 Added 33.37%	2,478 $205,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $101,394 - $145,567	-1,627 Reduced 46.69%	1,858 $159,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $190,885 - $218,040	3,206 Added 1149.1%	3,485 $215,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $146,666 - $165,190	-2,541 Reduced 90.11%	279 $17,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $163,334 - $204,675	2,820 New	2,820 $168,000
Q2 2021 Feb 11, 2022	SELL	$63.47 - $69.35 $86,446 - $94,454	-1,362 Closed	0 $0
Q1 2021 Feb 08, 2022	BUY	$60.0 - $68.46 $81,720 - $93,242	1,362 New	1,362 $88,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.